Metraipolis › archive › dc_bbb194982a5f
Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis — Europe PMC PMID:41262905
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41262905
- DOI
- 10.3389/fonc.2025.1613777
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:29:45.955Z
- SHA-256 of the archived text
cdac27076210f88cebbba52b4de6fd7cfc5977e082170dc61e71037259743cb9- Stable URL of this page
https://metraipolis.com/documento/dc_bbb194982a5f
How to cite
Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis — Europe PMC PMID:41262905 — Europe PMC (en), https://europepmc.org/article/MED/41262905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb194982a5f (Metraipolis archive dc_bbb194982a5f, sha256 cdac27076210f88cebbba52b4de6fd7cfc5977e082170dc61e71037259743cb9)
BibTeX
@misc{dcbbb194982a5f,
title = {Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis — Europe PMC PMID:41262905},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41262905},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb194982a5f; sha256 cdac27076210f88cebbba52b4de6fd7cfc5977e082170dc61e71037259743cb9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41262905. Agents can read the archived copy with the MCP tool read_document.